Evaluation of normal tissue complications in breast cancer re-irradiation: a meta-analysis study.
Biological effective dose
Breast cancer
Complication
Radiation therapy
Re-irradiation
Journal
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ISSN: 1699-3055
Titre abrégé: Clin Transl Oncol
Pays: Italy
ID NLM: 101247119
Informations de publication
Date de publication:
05 Aug 2024
05 Aug 2024
Historique:
received:
26
03
2024
accepted:
19
07
2024
medline:
6
8
2024
pubmed:
6
8
2024
entrez:
5
8
2024
Statut:
aheadofprint
Résumé
In recent years, evidence has accumulated that a second method of conserving the breast from cancer with re-irradiation as part of treatment may be feasible and safe. Many oncologists are skeptical of breast re-irradiation due to concerns about late complications, so access to quantitative data on the prevalence of breast re-irradiation complications is very important. In this meta-analysis, we determine the prevalence of complications in normal tissue after breast re-irradiation. A search was done to recognize qualified studies using EMBASE, MEDLINE, PUBMED, Google Scholar, and Cochrane Collaboration Library electronic databases from 2000 to 2023. In total, ten primary studies were applied in this meta-analysis to estimate the prevalence of complications of disorders, skin fibrosis, and chest pain. Heterogeneity was investigated using the I The average dose received by patients who underwent radiation therapy in two stages was 100.32 Gy, and in these patients, the prevalence of skin fibrosis and disorders was 47% (95% CI 71-22%; I There is little clinical information about the incidence of complications in breast re-irradiation therapy. This meta-analysis presents the prevalence of complications after breast re-irradiation to help radiation oncologists and physicists make better decisions.
Sections du résumé
BACKGROUND
BACKGROUND
In recent years, evidence has accumulated that a second method of conserving the breast from cancer with re-irradiation as part of treatment may be feasible and safe. Many oncologists are skeptical of breast re-irradiation due to concerns about late complications, so access to quantitative data on the prevalence of breast re-irradiation complications is very important. In this meta-analysis, we determine the prevalence of complications in normal tissue after breast re-irradiation.
MATERIALS AND METHODS
METHODS
A search was done to recognize qualified studies using EMBASE, MEDLINE, PUBMED, Google Scholar, and Cochrane Collaboration Library electronic databases from 2000 to 2023. In total, ten primary studies were applied in this meta-analysis to estimate the prevalence of complications of disorders, skin fibrosis, and chest pain. Heterogeneity was investigated using the I
RESULTS
RESULTS
The average dose received by patients who underwent radiation therapy in two stages was 100.32 Gy, and in these patients, the prevalence of skin fibrosis and disorders was 47% (95% CI 71-22%; I
CONCLUSIONS
CONCLUSIONS
There is little clinical information about the incidence of complications in breast re-irradiation therapy. This meta-analysis presents the prevalence of complications after breast re-irradiation to help radiation oncologists and physicists make better decisions.
Identifiants
pubmed: 39103729
doi: 10.1007/s12094-024-03632-z
pii: 10.1007/s12094-024-03632-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Références
Mo C, Ruan W, Lin J, Chen H, Chen X. Repeat breast-conserving surgery versus salvage mastectomy for ipsilateral breast tumour recurrence after breast-conserving surgery in breast cancer patients: a meta-analysis. Front Oncol. 2021;11: 734719.
doi: 10.3389/fonc.2021.734719
pubmed: 34888233
pmcid: 8650120
Merino-Lara TR, Tran WT, Czarnota GJ. Re-irradiation for locally recurrent refractory breast cancer. The Breast. 2015;24:S125.
doi: 10.1016/S0960-9776(15)70317-6
Borg A, Lennerstrand J, Stenmark-Askmalm M, Fernö M, Brisfors A, Ohrvik A, et al. Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols. Br J Cancer. 1995;71(5):1013–7.
doi: 10.1038/bjc.1995.195
pubmed: 7734292
pmcid: 2033772
Skinner HD, Strom EA, Motwani SB, Woodward WA, Green MC, Babiera G, et al. Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Radiat Oncol. 2013;8(1):1–9.
doi: 10.1186/1748-717X-8-13
Qu F-L, Mao R, Liu Z-B, Lin C-J, Cao A, Wu J, et al. Spatiotemporal patterns of loco-regional recurrence after breast-conserving surgery. Front Oncol. 2021;11: 690658.
doi: 10.3389/fonc.2021.690658
pubmed: 34527574
pmcid: 8435899
Lazzari G, Solazzo AP, Benevento I, Montagna A, Rago L, Castaldo G, et al. Current trends and challenges in real-world breast cancer adjuvant radiotherapy: a practical review.: New trends in adjuvant radiotherapy in BC. Arch Breast Cancer. 2023;10(1):6–14.
doi: 10.32768/abc.20231016-14
Dalberg K, Mattsson A, Sandelin K, Rutqvist LE. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat. 1998;49:69–78.
doi: 10.1023/A:1005934513072
pubmed: 9694613
Smanykó V, Mészáros N, Újhelyi M, Fröhlich G, Stelczer G, Major T, et al. Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences 5-year results. Brachytherapy. 2019;18(3):411–9.
doi: 10.1016/j.brachy.2019.02.004
pubmed: 30890318
Merino T, Tran WT, Czarnota GJ. Re-irradiation for locally recurrent refractory breast cancer. Oncotarget. 2015;6(33):35051.
doi: 10.18632/oncotarget.6036
pubmed: 26459388
pmcid: 4741508
Elfgen C, Güth U, Gruber G, Birrer S, Bjelic-Radisic V, Fleisch M, et al. Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective. Breast Cancer. 2020;27:1107–13.
doi: 10.1007/s12282-020-01114-y
pubmed: 32488732
Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321(7273):1371–6.
doi: 10.1136/bmj.321.7273.1371
pubmed: 11099280
pmcid: 27538
Raudenbush SW. Random effects models. The handbook of research synthesis, 1994. 421(3.6).
Abeloos CH, Purswani JM, Galavis P, McCarthy A, Hitchen C, Choi JI, et al. Different re-irradiation techniques after breast-conserving surgery for recurrent or new primary breast cancer. Curr Oncol. 2023;30(1):1151–63.
doi: 10.3390/curroncol30010088
pubmed: 36661737
pmcid: 9857440
Fattahi S, Ahmed SK, Park SS, Petersen IA, Shumway DA, Stish BJ, et al. Reirradiation for locoregional recurrent breast cancer. Adv Radiat Oncol. 2021;6(1): 100640.
doi: 10.1016/j.adro.2020.100640
pubmed: 33506143
Smoot B, Wampler M, Topp KS. Breast cancer treatments and complications: implications for rehabilitation. Rehabil Oncol. 2009;27(3):16–26.
doi: 10.1097/01893697-200927030-00004
Kao HS, Zhu L, Chao AA, Chen HY, Liu IC, Zhang M. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928403/Calligraphy and meditation for stress reduction: an experimental comparison.
Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999;43(4):755–62.
doi: 10.1016/S0360-3016(98)00412-X
pubmed: 10098430
Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.
doi: 10.1056/NEJMoa1209825
pubmed: 23484825
Day JN, Chau TT and Lalloo DG. Ischemic heart disease after breast cancer radiotherapy. 2013.
Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9.
doi: 10.1200/JCO.2016.72.0722
pubmed: 28319436
pmcid: 5548226
Henson K, McGale P, Taylor C, Darby S. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108(1):179–82.
doi: 10.1038/bjc.2012.575
pubmed: 23257897
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, et al. NRG oncology–radiation therapy Oncology group study 1014: 1-year toxicity report from a phase 2 study of repeat breast-preserving surgery and 3-dimensional conformal partial-breast reirradiation for in-breast recurrence. Int J Radiat Oncol Biol Phys. 2017;98(5):1028–35.
doi: 10.1016/j.ijrobp.2017.03.016
pubmed: 28721885
pmcid: 5572128
Abeloos CH, Xiao J, Oh C, Barbee D, Perez CA, Oratz R et al. Effectiveness and toxicity of re-irradiation after breast conserving surgery for recurrent or new primary breast cancer: a multi-institutional study. 2022.
Binkley MS, Hiniker SM, Chaudhuri A, Maxim PG, Diehn M, Loo BW Jr, et al. Dosimetric factors and toxicity in highly conformal thoracic reirradiation. Int J Radiat Oncol Biol Phys. 2016;94(4):808–15.
doi: 10.1016/j.ijrobp.2015.12.007
pubmed: 26831903
Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, et al. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys. 2008;70(2):477–84.
doi: 10.1016/j.ijrobp.2007.06.035
pubmed: 17869019
Müller A-C, Eckert F, Heinrich V, Bamberg M, Brucker S, Hehr T. Re-surgery and chest wall re-irradiation for recurrent breast cancer-a second curative approach. BMC Cancer. 2011;11(1):1–8.
doi: 10.1186/1471-2407-11-197
Arthur DW, Winter KA, Kuerer HM, Haffty B, Cuttino L, Todor DA, et al. Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG oncology/RTOG 1014 phase 2 clinical trial. JAMA Oncol. 2020;6(1):75–82.
doi: 10.1001/jamaoncol.2019.4320
pubmed: 31750868
Chan S, Rowbottom L, McDonald R, Bjarnason G, Tsao M, Danjoux C, et al. Does the time of radiotherapy affect treatment outcomes? A review of the literature. Clin Oncol. 2017;29(4):231–8.
doi: 10.1016/j.clon.2016.12.005
Forster T, Köhler CVK, Debus J, Hörner-Rieber J. Accelerated partial breast irradiation: a new standard of care? Breast Care. 2020;15(2):136–47.
doi: 10.1159/000506254
pubmed: 32398982
pmcid: 7204849
Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, et al. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol. 2021;165:142–51.
doi: 10.1016/j.radonc.2021.10.010
pubmed: 34688807
pmcid: 9554730
Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, et al. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2019;25(6):1160–70.
doi: 10.1111/tbj.13423
pubmed: 31338974
Draper L. Breast cancer: trends, risks, treatments, and effects. AAOHN J. 2006;54(10):445–53.
doi: 10.1177/216507990605401004
pubmed: 17059162
Siglin J, Champ CE, Vakhnenko Y, Anne PR, Simone NL. Radiation therapy for locally recurrent breast cancer. Int J Breast Cancer. 2012. https://doi.org/10.1155/2012/571946 .
doi: 10.1155/2012/571946
pubmed: 23091733
pmcid: 3471452
Burr AR, Robins HI, Bayliss RA, Howard SP. Pulsed reduced dose rate for reirradiation of recurrent breast cancer. Practical Radiation Oncology. 2020;10(2):61-70.
Chen I, Botty Van den Bruele AM, Gillespie EF, Mueller BA, Xu AJ, Cuaron J, et al. Salvage of locally recurrent breast cancer with repeat breast conservation using 45 Gy hyperfractionated partial breast re-irradiation. Breast Cancer Research and Treatment. 2021;188:409-14.
Harkenrider MM, Wilson MR, Dragun AE. Reirradiation as a component of the multidisciplinary management of locally recurrent breast cancer. Clinical Breast Cancer. 2011;11(3):171-6.
Janssen S, Rades D, Meyer A, Fahlbusch F, Wildfang I, Meier A, et al. Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention. Strahlentherapie und Onkologie. 2018;194(9):806-14.
Würschmidt F, Dahle J, Petersen C, Wenzel C, Kretschmer M, Bastian C. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. Radiation Oncology. 2008;3:1-9.